查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451122

静脉注射解决方案市场报告（按类型（部分肠外营养、全肠外营养）、营养素（碳水化合物、盐和电解质、矿物质、维生素、氨基酸）和地区）2024-2032

Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2023年全球静脉注射解决方案市场规模达148亿美元。展望未来， IMARC Group预计到2032年市场规模将达到232亿美元，2024-2032年复合年增长率（CAGR）为4.9%。慢性病盛行率的增加、老年人口的增加、技术的快速进步、医疗保健设施的不断扩张、政府和监管机构实施的支持政策以及家庭医疗保健的不断转变是推动市场的一些主要因素。

静脉注射 (IV) 溶液是指用于将液体直接注射到患者血液中的无菌液体。它包括等渗透压、高渗透压和低渗透压解决方案，满足不同的医疗需求。它们是使用各种成分生产的，例如水、电解质、糖、维生素和药物。静脉注射液广泛用于水合疗法、营养支持、药物传递、输血、化疗、疼痛管理、矫正电解质失衡和解毒治疗。它们具有多种优势，例如控制给药、减少消化系统影响、客製化营养输送、直接血流路径和增强恢復支持。

医院、诊所和专科护理中心等医疗机构的快速扩张，为静脉注射治疗创造了更多机会，推动了市场成长。此外，政府和监管机构为确保医疗机构提供高品质静脉注射解决方案而实施的支持政策正在对市场成长产生积极影响。此外，紧急情况和外科手术中对静脉注射解决方案的需求不断增长，也促进了市场的成长。除此之外，家庭医疗保健（患者在自己家中接受治疗）的日益转变正在促进对专业静脉注射解决方案的需求。除此之外，在全球突发卫生事件（例如流行病）期间快速治疗大量患者的产品应用不断增加，正在促进市场成长。

静脉解决方案市场趋势/驱动因素：

疾病盛行率不断增加

糖尿病、心血管疾病、癌症和急性疾病等慢性疾病的盛行率上升，需要静脉注射治疗，这是推动市场成长的重要因素。此外，新出现的全球趋势，如生活方式的改变、环境因素和遗传倾向，导致慢性病增加，也是另一个生长诱导因素。此外，一些慢性和急性疾病需要直接将液体、营养物质或药物注入血液中。据此，静脉注射解决方案有助于精确输送必需的营养素和药物，并确保患者快速康復。此外，它们还可以实现更快、更可控的护理，特别是在危急情况下。

老年人口不断增加

不断增长的老年人口对静脉注射解决方案市场的成长做出了重大贡献。老龄化人口对各种健康问题和慢性病的高度敏感，通常需要复杂的医疗干预措施，包括静脉注射治疗，正在推动市场成长。此外，免疫系统较弱、器官功能下降以及其他与年龄相关的生理变化使老年人更容易感染和疾病，这些都促进了市场的成长。与此一致的是，静脉注射解决方案对于提供必要的水合作用、营养和药物至关重要，确保治疗有针对性和有效。此外，广泛使用静脉注射溶液来恢復钠、钾、钙和镁等电解质的不平衡，是另一个生长诱导因子。

科技的快速进步

医疗保健和静脉注射解决方案生产的技术进步正在促进市场成长。与此一致的是，新技术使得能够制定更专业的解决方案，满足特定患者的需求，并提高静脉注射疗法的效率和安全性。此外，输液帮浦和输送系统的最新创新使医疗保健提供者能够更精确和控制地进行治疗，这对市场成长产生了积极影响。此外，监测和管理静脉注射治疗的技术突破可降低併发症风险并改善患者预后，这也是另一个生长诱导因素。此外，专注于生物相容性、个人化治疗计划以及人工智慧 (AI) 等整合技术以增强护理的广泛研发 (R&D) 工作正在支持市场成长。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球静脉注射解决方案市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔：按类型
  • 市场区隔：按营养素
  • 市场区隔：按地区
  • 市场预测
  • SWOT分析
    • 概述
    • 优势
    • 弱点
    • 机会
    • 威胁
  • 价值链分析
    • 概述
    • 研究与开发
    • 原物料采购
    • 製造业
    • 行销
    • 分配
    • 最终用途
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁

第 6 章：市场区隔：按类型

  • 部分肠外营养
    • 市场走向
    • 市场预测
  • 全肠外营养
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依营养素

  • 碳水化合物
    • 市场走向
    • 市场预测
  • 盐和电解质
    • 市场走向
    • 市场预测
  • 矿物质
    • 市场走向
    • 市场预测
  • 维生素
    • 市场走向
    • 市场预测
  • 胺基酸
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 9 章：静脉溶液製造工艺

  • 产品概述
  • 原料要求
  • 製造流程
  • 关键成功因素与风险因素

第 10 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Ajinomoto
    • B. Braun Melsungen
    • Baxter International Inc.
    • Grifols
    • Otsuka Pharmaceutical
Product Code: SR112024A891

The global intravenous solutions market size reached US$ 14.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032. The increasing prevalence of chronic diseases, rising geriatric population, rapid technological advancements, increasing expansion of healthcare facilities, imposition of supportive policies by governments and regulatory bodies, and rising shift towards home healthcare are some of the major factors propelling the market.

Intravenous (IV) solutions refer to sterile liquids used to administer fluids directly into a patient's bloodstream. It includes isotonic, hypertonic, and hypotonic solutions, catering to different medical needs. They are produced using various ingredients, such as water, electrolytes, sugars, vitamins, and medications. IV solutions are widely used in hydration therapy, nutritional support, medication delivery, blood transfusion, chemotherapy, pain management, correcting electrolyte imbalances, and detoxification treatments. They offer several benefits, such as controlled administration, reduced digestive system impact, tailored nutrient delivery, direct bloodstream access, and enhanced recovery support.

The rapid expansion of healthcare facilities, such as hospitals, clinics, and specialized care centers, which are generating more opportunities for IV treatments, is propelling the market growth. Additionally, the imposition of supportive policies by governments and regulatory bodies to ensure the availability of high-quality intravenous solutions across healthcare facilities is positively influencing the market growth. Furthermore, the growing demand for IV solutions in emergency scenarios and surgical procedures is contributing to the market growth. Apart from this, the increasing shift towards home healthcare, where patients receive treatment in their own homes, is facilitating the demand for specialized IV solutions. Besides this, the rising product application in treating a large number of patients quickly during global health emergencies, such as pandemics, is catalyzing the market growth.

Intravenous Solutions Market Trends/Drivers:

The increasing prevalence of disease

The heightened prevalence of chronic diseases, such as diabetes, cardiovascular ailments, cancer, and acute conditions, which necessitate IV treatments, is a prominent factor propelling the market growth. Furthermore, emerging global trends, such as lifestyle changes, environmental factors, and genetic predispositions, which lead to an increase in chronic conditions, are acting as another growth-inducing factor. Additionally, several chronic and acute illnesses require direct administration of fluids, nutrients, or medications into the bloodstream. In line with this, IV solutions facilitate precise delivery of essential nutrients and medication and ensure quick patient recovery. In addition, they also enable faster, more controlled care, particularly in critical situations.

The rising geriatric population

The rising geriatric population is contributing significantly to the growth of the IV solutions market. The high susceptibility of the aging population to various health issues and chronic conditions, which often require complex medical interventions, including IV therapy, is propelling the market growth. Furthermore, the presence of a weaker immune system, reduced organ functionality, and other age-related physiological changes that make geriatric individuals more prone to infections and diseases are facilitating the market growth. In line with this, IV solutions are vital in providing essential hydration, nutrients, and medications, ensuring that the treatments are targeted and efficient. Moreover, the widespread utilization of IV solutions to restore imbalance in electrolytes, such as sodium, potassium, calcium, and magnesium, is acting as another growth-inducing factor.

The rapid technological advancements

Technological advancements in medical care and the production of IV solutions are contributing to the market growth. In line with this, new technologies are enabling the formulation of more specialized solutions, catering to specific patient needs, and enhancing the efficiency and safety of IV therapies. Furthermore, the recent innovations in infusion pumps and delivery systems, which allow healthcare providers to administer treatments with greater precision and control, are positively influencing the market growth. Additionally, technological breakthroughs in monitoring and managing IV therapies to lower the risk of complications and improve patient outcomes are acting as another growth-inducing factor. Moreover, extensive research and development (R&D) efforts focusing on biocompatibility, personalized treatment plans, and integrating technology, such as artificial intelligence (AI), to augment care are supporting the market growth.

Intravenous Solutions Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intravenous solutions market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on type and nutrients.

Breakup by Type:

Partial Parenteral Nutrition

Total Parenteral Nutrition

Total parenteral nutrition dominates the market

The report has provided a detailed breakup and analysis of the market based on type. This includes partial parenteral nutrition and total parenteral nutrition. According to the report, total parenteral nutrition represented the largest segment.

Total parenteral nutrition (TPN) is dominating the market as it is used to fulfill all the nutritional requirements of patients who cannot eat or absorb enough food through regular digestive means. Additionally, it finds extensive applications across various medical fields, including oncology, gastroenterology, and intensive care units (ICUs). Furthermore, the rising number of chronic conditions, such as cancer and gastrointestinal diseases, that necessitate the use of TPN for nutritional support is propelling the market growth. Apart from this, increasing utilization of TPN to meet the nutritional needs of patients undergoing major surgical procedures is catalyzing the market growth. Moreover, the recent improvements in TPN formulation and administration technology, ensuring safer and more personalized nutrition support, are strengthening the market growth.

Breakup by Nutrients:

Carbohydrates

Salts and Electrolytes

Minerals

Vitamins

Amino Acids

A detailed breakup and analysis of the market based on the nutrients has also been provided in the report. This includes carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.

Carbohydrates serve as a primary energy source for the human body. They are essential in providing immediate energy, particularly for patients unable to consume food orally. In addition, they are used by all cells in the body, which makes them suitable for a diverse range of patients, irrespective of their specific conditions. Furthermore, carbohydrates can be easily administered through IV solutions, allowing for controlled delivery.

Minerals, such as magnesium, calcium, potassium, and sodium, play critical roles in maintaining various bodily functions, including muscle contraction, nerve transmission, and maintaining fluid balance. Furthermore, IV solutions with specific mineral compositions are essential in correcting electrolyte imbalance, restoring normal cellular function, and stabilizing the patient. Apart from this, minerals are utilized in various medical scenarios, from emergency care to post-operative recovery and chronic disease management.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance, accounting for the largest intravenous solutions market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America hosts one of the world's most advanced healthcare systems comprising state-of-the-art medical facilities equipped with cutting-edge technology that is fostering a conducive environment for the utilization of IV solutions. Additionally, the region's healthcare spending is among the highest globally, enabling greater access to quality medical care, including treatments requiring intravenous solutions. Furthermore, the implementation of a comprehensive regulatory framework by the regional governments to ensure that IV solutions meet strict quality and safety standards is boosting the market growth. Apart from this, the high prevalence of chronic conditions like diabetes, heart disease, and cancer, which necessitates regular medical interventions, is acting as another growth-inducing factor. Besides this, North America has a strong network of universities, research institutions, and pharmaceutical companies that are actively investing in developing new intravenous solutions and improving existing ones.

Competitive Landscape:

The major players are focusing on creating advanced intravenous products, such as the formulation of new solutions with improved efficiency, the integration of innovative technologies like smart infusion pumps, and the development of personalized therapies. In addition, they are expanding their reach into these regions by setting up new manufacturing facilities, partnering with local distributors, and adapting products to meet specific regional needs. Furthermore, leading companies are engaging in mergers and acquisitions to diversify their product portfolios, leverage synergies, and expand their geographical presence. Moreover, they are placing strong emphasis on quality control and regulatory compliance to ensure that their products meet all relevant safety and efficacy standards. Besides this, top companies in the IV solutions market are focusing on environmentally responsible manufacturing processes and materials by reducing waste and energy consumption and using sustainable resources.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Ajinomoto Co., Inc.

B. Braun Melsungen AG

Baxter International, Inc.

Grifols S.A.

Otsuka Pharmaceutical.

Recent Developments:

In February 2022, B. Braun Medical has obtained approval from the U.S. Food and Drug Administration to commence activities at its recently established manufacturing facility for IV saline solutions located in Daytona Beach, Florida.

In July 2021, Grifols S.A. announced the establishment of an intravenous (IV) solutions production plant in Nigeria.

In March 2022, Otsuka Pharmaceutical. received regulatory approval in Japan for the sale of SAMTASU intravenous infusion for treating cardiac edema.

Key Questions Answered in This Report

  • 1. What is the expected growth rate of the global intravenous solutions market during 2024-2032?
  • 2. What are the key factors driving the global intravenous solutions market?
  • 3. What has been the impact of COVID-19 on the global intravenous solutions market?
  • 4. What is the breakup of the global intravenous solutions market based on the type?
  • 5. What is the breakup of the global intravenous solutions market based on the nutrients?
  • 6. What are the key regions in the global intravenous solutions market?
  • 7. Who are the key players/companies in the global intravenous solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Nutrients
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Partial Parenteral Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Total Parenteral Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Nutrients

  • 7.1 Carbohydrates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Salts and Electrolytes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Minerals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitamins
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Amino Acids
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intravenous Solutions Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Ajinomoto
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 B. Braun Melsungen
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Baxter International Inc.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Grifols
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Otsuka Pharmaceutical
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2023
  • Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
  • Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
  • Figure 9: Global: Intravenous Solutions Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2024-2032
  • Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Intravenous Solutions: Raw Material Requirements
  • Table 6: Global: Intravenous Solutions Market: Competitive Structure
  • Table 7: Global: Intravenous Solutions Market: Key Players